Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Kevin J BarnhamAshley I Bush

Abstract

Alzheimer's disease (AD) is characterized by the presence of neurofibrillary tangles and amyloid plaques, which are abnormal protein deposits. The major constituent of the plaques is the neurotoxic beta-amyloid peptide (Abeta); the genetics of familial AD support a direct role for this peptide in AD. Abeta neurotoxicity is linked to hydrogen peroxide formation. Abeta coordinates the redox active transition metals, copper and iron, to catalytically generate reactive oxygen species. The chemical mechanism underlying this process is not well defined. With the use of density functional theory calculations to delineate the chemical mechanisms that drive the catalytic production of H2O2 by Abeta/Cu, tyrosine10 (Y10) was identified as a pivotal residue for this reaction to proceed. The relative stability of tyrosyl radicals facilitates the electron transfers that are required to drive the reaction. Confirming the theoretical results, mutation of the tyrosine residue to alanine inhibited H2O2 production, Cu-induced radicalization, dityrosine cross-linking, and neurotoxicity.

References

Jul 1, 1981·Journal of Neuropathology and Experimental Neurology·D W Vaughan, A Peters
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·J NäslundP Greengard
Feb 23, 1996·The Journal of Biological Chemistry·Y M KuoA E Roher
Nov 15, 1996·Analytical Biochemistry·D A MalencikS R Anderson
Apr 1, 1997·Trends in Neurosciences·J Hardy
Feb 6, 1999·Annual Review of Physical Chemistry·R I Cukier, D G Nocera
Mar 29, 2001·Physiological Reviews·D J Selkoe
Feb 28, 2003·Journal of Neuroscience Research·Anthony R White, Roberto Cappai
Mar 27, 2003·Journal of the American Chemical Society·Maria WirstamRichard A Friesner
Apr 12, 2003·Trends in Neurosciences·Ashley I Bush
Apr 26, 2003·Current Opinion in Chemical Biology·Melanie S Rogers, David M Dooley
Jun 12, 2003·Chemical Reviews·James W Whittaker
Aug 20, 2003·The Journal of Biological Chemistry·Kevin J BarnhamRoberto Cappai
Aug 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yuesong GongWilliam L Klein
Jan 14, 2004·Biochemistry·Craig S AtwoodAshley I Bush

❮ Previous
Next ❯

Citations

Nov 22, 2007·European Biophysics Journal : EBJ·Geoffrey K-W KongMichael W Parker
Jan 29, 2013·Acta Neuropathologica·Andrew D WattKevin J Barnham
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ashley I Bush, Rudolph E Tanzi
Sep 15, 2005·Biochemistry·Ian V J MurrayPaul H Axelsen
May 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kevin J BarnhamRoberto Cappai
Jan 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Peter J CrouchKevin J Barnham
Aug 30, 2005·The Journal of Clinical Investigation·Luigi PuglielliAshley I Bush
Jul 4, 2012·International Journal of Molecular Sciences·Xueling DaiZhaofeng Jiang
Jun 7, 2014·Molecular Neurodegeneration·Dolores Del PreteMounia Chami
Dec 27, 2013·International Journal of Alzheimer's Disease·Xin Yi ChooAlexandra Grubman
Jan 15, 2011·International Journal of Alzheimer's Disease·Chia-Anne YangYi-Cheng Chen
Jul 30, 2014·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Rosanna Squitti
Oct 21, 2015·ACS Chemical Neuroscience·David I FinkelsteinPaul A Adlard
Apr 12, 2016·Frontiers in Pharmacology·Lieven D DeclercqGuy Bormans
Aug 8, 2015·Accounts of Chemical Research·Chandradeep GhoshSomdatta Ghosh Dey
Aug 25, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Ming Wai HungSimon Ming Yuen Lee
Dec 20, 2013·Acta Neuropathologica Communications·Youssra K Al-HilalyLouise C Serpell
May 27, 2014·Frontiers in Aging Neuroscience·Bruce X WongJames A Duce
Sep 7, 2007·The International Journal of Biochemistry & Cell Biology·Peter J CrouchColin L Masters
Mar 18, 2008·Current Opinion in Chemical Biology·Kevin J Barnham, Ashley I Bush
Feb 24, 2018·Frontiers in Aging Neuroscience·Soghra BagheriAli A Saboury
Aug 5, 2004·The Journal of Biological Chemistry·Giuseppe D CiccotostoKevin J Barnham
Jun 30, 2006·Journal of Neurochemistry·Colin L MastersVictor L Villemagne
Aug 23, 2006·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Luc GuilloreauPeter Faller
Dec 8, 2007·European Biophysics Journal : EBJ·Ryan NaylorKevin J Barnham
Nov 13, 2007·European Biophysics Journal : EBJ·Ashley I Bush, Cyril C Curtain
Jan 26, 2008·European Biophysics Journal : EBJ·John D GehmanFrances Separovic
Feb 8, 2008·European Biophysics Journal : EBJ·John F BoasCyril C Curtain
Feb 14, 2008·European Biophysics Journal : EBJ·Gulay FilizAnthony R White
Jul 9, 2008·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Yogita MantriMu-Hyun Baik
Dec 2, 2008·Journal of Cellular and Molecular Medicine·Yif'at BiranPaul A Adlard
Dec 31, 2008·Chembiochem : a European Journal of Chemical Biology·Yuichi MasudaKazuhiro Irie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.